Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Sep 8.
Published in final edited form as: Angew Chem Int Ed Engl. 2014 Aug 3;53(37):9851–9855. doi: 10.1002/anie.201406622

Simple Sulfinate Synthesis Enables C–H Trifluoromethylcyclopropanation

Ryan Gianatassio 1, Shuhei Kawamura 2, Cecil L Eprile 3, Klement Foo 4, Jason Ge 5, Aaron C Burns 6, Michael R Collins 7, Phil S Baran 8,
PMCID: PMC4186797  NIHMSID: NIHMS626773  PMID: 25088979

Abstract

A simple method to convert readily available carboxylic acids into sulfinate salts employing an interrupted Barton decarboxylation reaction is reported. A medicinally oriented panel of ten new sulfinate reagents was created using this method, including a key trifluoromethylcyclopropanation reagent TFCS-Na. The reactivity of six of these salts towards C–H functionalization was field-tested using several different classes of heterocycles.

Keywords: bioisosteres, sulfinate salts, heterocycles, C–H functionalization, analogue synthesis


The decoration of C–H bonds on heteroarenes using radicals generated from sulfinate salts has emerged as a predictable and chemoselective method for both the early and late stages of a synthesis,1 for the prediction and prevention of drug metabolism,2 and for the native chemical tagging of complex molecules.3 In a recent report, a sulfinate salt was used to append a trifluoromethyl group onto (−)-agelastatin A, which led to the synthesis of the most potent derivative of this natural product.4 The surging commercial demand for sulfinate reagents pointed to a clear drawback in that only a limited set are currently available. In contrast to their more widely available relatives, carboxylic acids, sulfinates have a significantly weaker barrier for homolysis leading to alkyl radicals (as judged by bond dissociation energies, Figure 1A). The relatively weak C–S bond in sulfinates makes them ideal radical precursors as compared to carboxylic acids which often require strong oxidants, heat, light, specialized transition metal catalysts, or further functionalization.5 In this communication, we report a simple procedure for the conversion of a variety of carboxylic acids to sulfinate salts thus enabling the direct synthesis of a variety of important bioisosteres and setting the stage for significant expansion of the commercially available sulfinate toolkit.

Figure 1.

Figure 1

A. Logic behind conversion of carboxylic acids to sulfinates; ubiquitous but less reactive carboxylic acids could be used as precursors to rare but useful sulfinates. B. The “interrupted” Barton reaction allows for the development of a high-value reagent for the introduction of isosteric units for medicinal chemistry.

The invention of a route to sulfinate salts from carboxylic acids was actually prompted by a recent report from a group at Novartis where the trifluoromethylcyclopropyl group was found to function as a metabolically stable replacement for a tert-butyl moiety.6 The introduction of this group was problematic, and the reported method requires a multi-step synthesis (using diazomethane), thus making it an excellent candidate for a C–H functionalization strategy using sulfinates. The commercial availability of acid 1 conveniently allowed us to determine if it was even necessary to invent such a reagent bearing this motif (2). As shown in Figure 1B, classic Minisci conditions were screened using a variety of acids and temperatures with caffeine as the test substrate, and no product (2A) was detected by LC/MS. These findings are consistent with our previous studies where Minisci conditions generally fail when using fluorinated acids.1 We then turned to Barton’s classic work on visible light mediated photolytic radical formation from O-esters of thiohydroxamic acids.7 Acid 1 was converted to ester 3, which was subjected to Barton’s conditions for the generation of alkyl radicals and Minisci-type addition in the presence of a Brønsted acid.8 Although we were able to reproduce the reported addition of adamantyl radical to caffeine, the identical conditions using 3 as radical donor in either DMF or CH2Cl2 led to less than 1% conversion by LC/MS. Upon further analysis, the attempted homolysis of 3 led to small quantities of thiopyridyl substrate 4, an intermediate that represented a possible pathway to sulfinate 2. After extensive solvent screening, ethyl acetate was found to be the optimal medium to obtain synthetically useful yields of 4. This empirical finding is useful given the reported inefficiency of the “interrupted” Barton decarboxylation on small-sized ring systems. Subsequent oxidation using RuCl3 was facile and cleavage of pyridine with NaOEt led to the coveted trifluoromethylcyclopropyl sulfinate salt in 75% isolated yield (TFCS-Na, 2, structure verified by x-ray, CCDC # 1010780). To our delight, when caffeine was exposed to sulfinate salt 2 (3.0 equiv) and TBHP (5.0 equiv) at 60 °C significant amounts of 2A were observed by LC/MS. After screening various solvents and temperatures, a mixture of diethylcarbonate and water (3: 2) at 90 °C led to a 71% isolated yield of 2A after only one hour. The elevated temperature relative to other sulfinate additions is presumably required to generate the radical and forge the quaternary carbon center.

As illustrated in Table 1, this protocol for the net conversion of carboxylic acids to sulfinate salts is simple and general. The sequence involves only one isolated intermediate (sulfone) with the intermediate Barton ester carried on crude after aqueous workup, and the rearranged sulfide submitted directly to the RuCl3-catalyzed oxidation. Ten different sulfinate reagents were prepared using this route and ranged in structural complexity, fluorine content, and heteroatom presence.9

Table 1.

Conversion of readily available carboxylic acids into sulfinate reagents. Conditions: A) carboxylic acid (1 equiv), (COCl)2 (1.5 equiv), DMF (0.1 equiv), 0 to 23 °C; B) 250 W or 600 W tung sten lamp, EtOAc; C) RuCl3 (5 mol%), NaIO4 (6 equiv), EtOAc:H2O; D) NaOEt (1.1 equiv), DMA, 0 to 30 °C or NaSEt, THF, 0 to 23 °C.

graphic file with name nihms626773t1.jpg

In addition to TFCS-Na 2, several other salts may find use in medicinal chemistry programs. It is important to note that difluorinated congeners of common cyclic ethers were synthesized as isosteric replacements of oxygen (e.g. 14). Azetidine 23 could be used to increase solubility of medicinally relevant compounds, and removal of the Boc group could lead to further derivatization. Other sulfinates such as 17, 20, and 29 contain motifs popular in medicinal chemistry10 and they were selected for commercialization. As such, their synthesis was conducted on multi-gram scale.

The C–H functionalization of four different classes of heterocycles AD was explored with these six newly commercialized sulfinate salts (Table 2). All of these sulfinates gave products in good to moderate yields. As can be expected with sulfinate chemistry, these reactions are conducted under air, in the presence of water, and without using transition metals, which makes them very practical and operationally simple. As observed with 1 (Figure 1B), standard Minisci reaction conditions were screened with caffeine (RCO2H, AgNO3, (NH4)2S2O8 and H2SO4 in H2O at 90 °C) using 12, 15, 18, 21, and 27, but zero or slight conversion (less than 5%) was observed.11 Although we only tested the potential of some of these new salts for C–H functionalization, sulfinate salts have shown reactivity in cross-coupling and can be converted to other functional groups such as sulfonamides.12,13

Table 2.

Reactions of newly designed sodium alkanesulfinate salts and heteroarenes. Reactions were performed on 0.1 or 0.2 mmol scale. Standard conditions: Heterocycle (1 equiv), sulfinate salt (3 equiv), tert-butyl hydroperoxide (TBHP, 5.0 equiv), 0 to 90 °C. Yields of chromatographically pure products are displayed, unless otherwise noted.

graphic file with name nihms626773t2.jpg
a

Sigma–Aldrich Catalog number.

b

6.0 equiv of the sulfinate salt and 10 equiv of TBHP were used.

This method compares well with other state-of-the-art routes to introduce medicinally important functional groups onto heteroarenes. For example, sulfinate salt 14 allows for the facile attachment of a difluorinated isostere of a tetrahydropyran ring onto a heterocycle, which would otherwise require 4 steps to install starting from the corresponding carboxylic acid.14 Another method to directly append tetrahydropyran, tetrahydrofuran, azetidine, and cyclobutane rings onto heteroarenes has been developed by Molander.15 Also, a trifluoropropyl group can be incorporated into a heteroarene through a condensation reaction with 4,4,4-trifluorobutanal, 2-oxopropanal and ammonium hydroxide.16 However, the only method to directly append a cyclopropyltrifluoromethyl group onto a heteroarene is achieved using sulfinate radical chemistry.

Lastly, attention was turned to one of the highlighted substrates in the Novartis report: bis-pyridine 35 (Scheme 1). The reported synthesis started from 33, a compound with limited availability but easily prepared from 2,5-dibromopyridine. Three steps are required to convert 33 to the trifluoromethylcyclopropyl pyridine 34. A final (presumably unoptimized) Suzuki coupling proceeded in 3% yield to furnish 35. In stark contrast, commercially available pyridine 36 bearing a C-3 boron functionality could be trifluoromethylcyclopropanated using 2 to chemoselectively furnish 37. This intermediate was used directly without isolation or purification in a Suzuki coupling to afford 35 in 37% isolated yield over the two-step, one-pot operation.

Scheme 1.

Scheme 1

Comparison of conventional and C–H functionalization routes to 35. A) Reaction performed on 0.05 mmol scale. Reagents and conditions: 36 (1 equiv), 2 (3.0 equiv), tert-butylhydroperoxide (TBHP, 5.0 equiv), 0 to 90 °C; then 2-bromo-5-cyanopyridine (1.1 equiv), Pd(PPh3)4, DME:H2O (3:1), reflux.

In summary, a simple sequence to convert widely available carboxylic acids into sulfinate salts has been devised using classic Barton chemistry. Several of these salts were commercialized and used to functionalize a panel of heterocycles. The simplicity of this C–H functionalization (a cheap industrial oxidant, simple solvent, and no metals) is a clear advantage over other radical donors. Judging from the demonstrated utility of these and other sulfinate salts at Pfizer we anticipate their rapid adoption for use in drug discovery.

Supplementary Material

Supporting Information

Acknowledgments

Financial support for this work was provided by the NIH/NIGMS (GM-106210), Sigma-Aldrich, Inc., Pfizer, Inc., Uehara Memorial Foundation (postdoctoral fellowship for S. K.), and A*STAR (predoctoral fellowship for K. F.). We are grateful to Prof. A. L. Rheingold and Dr. C. E. Moore (UCSD) for X-ray crystallographic analysis, Dr. D.-H. Huang and Dr. L. Pasternack for assistance with NMR spectroscopy, and M. A. Ornelas for technical assistance.

Footnotes

Supporting information for this article is available on the WWW under http://www.angewandte.org or from the author.

Contributor Information

Ryan Gianatassio, Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037.

Shuhei Kawamura, Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037.

Cecil L Eprile, Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037.

Klement Foo, Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037.

Jason Ge, Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037.

Aaron C. Burns, Department of Chemistry, Pfizer Pharmaceuticals, La Jolla Laboratories, 10770 Science Center Drive, La Jolla, California 92121

Michael R. Collins, Department of Chemistry, Pfizer Pharmaceuticals, La Jolla Laboratories, 10770 Science Center Drive, La Jolla, California 92121

Phil S. Baran, Email: pbaran@scripps.edu, Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037.

References

  • 1.a) Ji Y, Brueckl T, Baxter RD, Fujiwara Y, Seiple IB, Su S, Blackmond DG, Baran PS. Proc. Natl. Acad. Sci. USA. 2011;108:14411–14415. doi: 10.1073/pnas.1109059108. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Fujiwara Y, Dixon JA, Rodriguez RA, Baxter RD, Dixon DD, Collins MR, Blackmond DG, Baran PS. J. Am. Chem. Soc. 2012;134:1494–1497. doi: 10.1021/ja211422g. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Fujiwara Y, Dixon JA, O’Hara F, Daa Funder E, Dixon DD, Rodriguez RA, Baxter RD, Herlé B, Sach N, Collins MR, Ishihara Y, Baran PS. Nature. 2012;492:95–99. doi: 10.1038/nature11680. [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Zhou Q, Ruffoni A, Gianatassio R, Fujiwara Y, Sella E, Shabat D, Baran PS. Angew. Chem. Int. Ed. 2013;52:3949–3952. doi: 10.1002/anie.201300763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.O'Hara F, Burns AC, Collins MR, Dalvie D, Ornelas MA, Vaz ADN, Fujiwara Y, Baran PS. J. Med. Chem. 2014;57:1616–1620. doi: 10.1021/jm4017976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Zhou Q, Gui J, Pan C-M, Albone E, Cheng X, Suh EM, Grasso L, Ishihara Y, Baran PS. J. Am. Chem. Soc. 2013;135:12994–12997. doi: 10.1021/ja407739y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Stout EP, Choi M, Castro JE, Molinski TF. J. Med. Chem. 2014 doi: 10.1021/jm4016922. ASAP. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.a) Haynes WM, editor. Bond Dissociation Energies in CRC Handbook of Chemistry and Physics, 95th Edition (Internet Version 2015) Boca Raton, FL: CRC Press/Taylor and Francis; [Google Scholar]; b) Good A, Thynne JCJ. Trans. Faraday Soc. 1967;63:2708–2720. [Google Scholar]
  • 6.Barnes-Seeman D, Jain M, Bell L, Ferreira S, Cohen S, Chen XH, Amin J, Snodgrass B, Hatsis P. ACS Med. Chem. Lett. 2013;4:514–516. doi: 10.1021/ml400045j. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.a) Barton DHR, Crich D, Motherwell WB. J. Chem. Soc., Chem. Commun. 1983:939–941. [Google Scholar]; b) Barton DHR, Kretzschmar G. Tetrahedron Lett. 1983;24:5889–5892. [Google Scholar]; c) Barton DHR, Crich D, Kretzschmar G. Tetrahedron Lett. 1984;25:1055–1058. [Google Scholar]; d) Barton DHR, Crich D, Potier P. Tetrahedron Lett. 1985;26:5943–5946. [Google Scholar]; e) Barton DHR, Crich D, Motherwell WB. Tetrahedron. 1985;41:3901–3924. [Google Scholar]; f) Barton DHR, Bridon D, Zard SZ. Heterocycles. 1987;25:449–462. [Google Scholar]; g) Barton DHR, Bridon D, Fernandaz-Picot I, Zard SZ. Tetrahedron. 1987;43:2733–2740. [Google Scholar]; h) Barton DHR, Lacher B, Misterkiewicz B, Zard SZ. Tetrahedron. 1988;44:1153–1158. [Google Scholar]; i) Barton DHR, Ozbalik N, Vacher B. Tetrahedron. 1988;44:3501–3512. [Google Scholar]; j) Barton DHR, Halley F, Ozbalik N, Schmitt M, Young E, Balavoine G. J. Am. Chem. Soc. 1989;111:7144–7149. [Google Scholar]; k) Barton DHR, Jaszberenyi JC, Tang D. Tetrahedron Lett. 1993;34:3381–3384. [Google Scholar]; l) Barton DHR, Chern C-Y, Jaszberenyi JC, Shinada T. Tetrahedron Lett. 1993;34:6505–6508. [Google Scholar]; m) Barton DHR, Gateau-Olesker A, Géro SD, Lacher B, Tachdjian C, Zard SZ. Tetrahedron. 1993;49:4589–4602. [Google Scholar]; n) Barton DHR, Liu W. Tetrahedron Lett. 1997;38:2431–2434. [Google Scholar]
  • 8.a) Castagnino E, Corsano S. Tetrahedron Lett. 1986;27:6337–6338. [Google Scholar]; b) Barton DHR, Garcia B, Togo H, Zard SZ. Tetrahedron Lett. 1986;27:1327–1330. [Google Scholar]
  • 9.It has been shown that potassium trifluoromethanesulfinate can be prepared from potassium trifluoroacetate by treatment with SO2 (g) at 140 °C in DMF. See: Besson B. US2009/216036. 2009
  • 10.a) Desai RC, Gratale DF, Han W, Koyama H, Metzger E, Lombardo VK, MacNaul KL, Doebber TW, Berger JP, Leung K, Franklin R, Moller DE, Heck JV, Sahoo SP. Bioorg. Med. Chem. Lett. 2003;13:3541–3544. doi: 10.1016/s0960-894x(03)00785-6. [DOI] [PubMed] [Google Scholar]; b) Ontoria JM, Bufi LL, Torrisi C, Bresciani A, Giomini C, Rowley M, Serafini S, Bin H, Hao W, Steinkuhler C, Jones P. Bioorg. Med. Chem. Lett. 2011;21:5274–5282. doi: 10.1016/j.bmcl.2011.07.031. [DOI] [PubMed] [Google Scholar]; c) Liu L, Norman MH, Lee M, Xi N, Siegmund A, Boezio AA, Booker S, Choquette D, D'Angelo ND, Germain J, Yang K, Yang Y, Zhang Y, Bellon SF, Whittington DA, Harmange JC, Dominguez C, Kim TS, Dussault I. J. Med. Chem. 2012;55:1868–1897. doi: 10.1021/jm201331s. [DOI] [PubMed] [Google Scholar]; d) Waddell ST, Santorelli GM, Maletic MM, Leeman AH, Gu X, Graham DW, Balkovec JM, Aster SD. US2004/133011. 2004 [Google Scholar]
  • 11.Jain R, Vaitilingam B, Nayyar A, Palde PB. Bioorg. Med. Chem. Lett. 2003;13:1051–1054. doi: 10.1016/s0960-894x(03)00074-x. [DOI] [PubMed] [Google Scholar]
  • 12.a) Li ZJ, Cui ZL, Liu ZQ. Org. Lett. 2013;15:406–409. doi: 10.1021/ol3034059. [DOI] [PubMed] [Google Scholar]; b) Ye YD, Kuenzi SA, Sanford MS. Org. Lett. 2012;14:4979–4981. doi: 10.1021/ol3022726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.a) Alig L, Alsenz J, Andjelkovic M, Bendels S, Bernardeau A, Bleicher K, Bourson A, David-Pierson P, Guba W, Hildbrand S, Kube D, Lubbers T, Mayweg AV, Narquizian R, Neidhart W, Nettekoven M, Plancher JM, Rocha C, Rogers-Evans M, Rover S, Schneider G, Taylor S, Waldineier P. J. Med. Chem. 2008;51:2115–2127. doi: 10.1021/jm701487t. [DOI] [PubMed] [Google Scholar]; b) Johnson MW, Bagley SW, Mankad NP, Bergman RG, Mascitti V, Toste FD. Angew. Chem. Int. Ed. 2014;53:4404–4407. doi: 10.1002/anie.201400037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Banville J, Rémillard R, Ruediger EH, Deon DH, Gagnon M, Dúbe L, Guy J, Priestly ES, Posy SL, Maxwell BD, Wong PC. WO2013/163279. 2013 [Google Scholar]
  • 15.a) Presset M, Fleury-Bregeot N, Oehlrich D, Rombouts F, Molander GA. J. Org. Chem. 2013;78:4615–4619. doi: 10.1021/jo4005519. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Molander GA, Colombel V, Braz VA. Org. Lett. 2011;13:1852–1855. doi: 10.1021/ol2003572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Malmas MS, Ni Y, Edrei JJ, Stange H, Schindler R, Hofgen N, Egerland U, Langen B. US2009/14336. 2009 [Google Scholar]
  • 17.Oballa R. WO2006/133559. 2006 [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES